Eton Pharmaceuticals ETON Income Statement (2017-2026)

NASDAQ ETON
$61.40 -0.08 (-0.14%)
At close: Aug 20, 2026 · 12:47 PM UTC
1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue (Quarter)
0.00B0.00B0.01B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.03B0.01B0.01B0.01B0.01B0.02B0.02B0.02B0.02B0.04B
Cost of Revenue (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.01B
Gross Profit (Quarter)
0.00B0.00B0.01B0.00B0.00B0.00B0.01B0.00B0.01B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.03B
Operating items
Research & Development (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B
Selling, General & Administrative (Quarter)
0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.01B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Other Operating Expenses (Quarter)
0.00B
Operating Expenses (Quarter)
0.01B0.01B0.00B0.01B0.01B0.00B0.01B0.01B0.01B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Operating Income (Quarter)
-0.00B-0.01B0.00B-0.01B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B-0.00B-0.00B-0.00B0.00B0.01B
EBIT (Quarter)
-0.00B-0.01B0.00B-0.01B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B-0.00B-0.00B-0.00B0.00B0.01B
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
0.00B0.00B0.00B-0.00B0.00B
Non Operating Income (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Net income details
EBT (Quarter)
-0.00B-0.01B0.00B-0.01B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.01B
Tax Provisions (Quarter)
-0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B-0.00B0.00B
Profit After Tax (Quarter)
-0.00B-0.01B0.00B-0.01B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.01B
Income from Continuing Operations (Quarter)
-0.00B-0.01B0.00B-0.01B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.01B
Consolidated Net Income (Quarter)
-0.00B-0.01B0.00B-0.01B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.01B
Income towards Parent Company (Quarter)
-0.00B-0.01B0.00B-0.01B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.01B
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-0.00B-0.01B0.00B-0.01B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.01B
Additional items
EPS (Basic) (Quarter)
-0.08-0.240.04-0.21-62.01-0.120.11-0.100.18-0.02-0.07-31.48-117.9724.21-0.02-0.060.00-0.070.060.42
EPS (Diluted) (Quarter)
-0.08-0.240.04-0.21-62.01-0.120.11-104.210.18-0.02-0.07-31.48-117.9723.62-22.52-59.21-97.36-0.070.060.35
Shares Outstanding (Quarter)
0.03B0.03B0.03B0.03B0.00B0.03B0.03B0.03B0.03B0.03B0.03B0.00B0.00B0.00B0.03B0.03B26.89B0.03B0.03B0.03B
Shares Outstanding (Diluted) (Quarter)
0.03B0.03B0.03B0.03B0.00B0.03B0.03B0.00B0.03B0.03B0.03B0.00B0.00B0.00B0.00B0.00B0.00B0.03B0.03B0.03B
Shares Outstanding (Entity) (Quarter)
0.02B0.02B0.02B0.02B0.00B0.03B0.03B0.03B0.03B0.03B0.03B0.00B0.00B0.00B0.03B0.03B26.89B0.03B0.03B0.03B
EBITDA (Quarter)
-0.00B-0.01B0.00B-0.01B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B-0.00B-0.00B-0.00B0.00B0.01B
Interest Expenses (Quarter)
0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.05B0.05B0.10B0.00B0.16B
Tax Rate (Quarter)
-207.68%7.22%-1.81%-25.15%-17.03%-4.94%-2.62%1.43%-19.94%1.19%